Search

Heron Therapeutics Inc

Lezárt

SzektorEgészségügy

0.31 3.33

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

0.3

Maximum

0.32

Fő mutatók

By Trading Economics

Bevétel

2.6M

-5.5M

Értékesítés

3M

38M

Egy részvényre jutó nyereség

-0.03

Profit margin

-14.573

Munkavállalók

128

EBITDA

2.1M

-5.5M

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 3.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-37M

60M

Előző nyitás

-3.02

Előző zárás

0.31

Hangulat hírek alapján

By Acuity

50%

50%

129 / 339 Rangsor szerint Healthcare

Heron Therapeutics Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. szept. 15. 23:56 UTC

News

Lululemon Athletica shares are lower in after-market hours amid an investigation into potential securities law violations following a revenue guidance cut.

2026. szept. 15. 23:41 UTC

Correlated Moves
News

Heartland Express shares are lower in after-market trading, influenced by declines in Schneider National and concerns from the New York Empire State Manufacturing Index.

2026. szept. 15. 23:41 UTC

Correlated Moves
News

Tower Semiconductor shares are lower in after-market hours amid broader market dynamics and rising treasury yields ahead of the Federal Reserve's policy decision.

2026. szept. 15. 23:31 UTC

News

Xylem Inc. shares declined in after-market hours following a $1.5 billion senior notes offering, reflecting broader market trends and shifting investor sentiment.

2026. szept. 15. 23:26 UTC

News

Phil Poliquin has been appointed senior vice president at United Bankshares, focusing on government contracting. Shares are roughly flat in after-market trading.

2026. szept. 15. 23:16 UTC

News

FedEx shares are lower in after-market trading following the appointment of Mike Rodgers as Chief Commercial and Technology Officer amid broader market pressure.

2026. szept. 15. 23:16 UTC

News

Royalty Pharma announced a $7.5 million donation to Blood Cancer United. Shares are lower in after-market trading amid rising Treasury yields.

2026. szept. 15. 23:11 UTC

News

Coca-Cola Europacific Partners PLC gains in after-market hours on a planned $10 billion investment in U.S. infrastructure through 2030, focusing on production and distribution.

2026. szept. 15. 23:06 UTC

News

FuelCell Energy shares rise in after-hours trading following insider purchases. Director John Livingston bought 26.3K shares for $247K on September 14.

2026. szept. 15. 23:06 UTC

News

Apple Inc. shares rose in after-market trading following a product event that introduced new offerings and received an "Overweight" rating from Morgan Stanley with a $360 target.

2026. szept. 15. 23:06 UTC

Correlated Moves
News

Blackstone Inc's shares are higher in after-market trading, likely influenced by KKR & Co Inc's recovery and recent IPO activity highlighted by CFO Michael Chae.

2026. szept. 15. 23:06 UTC

News

UnitedHealth Group will release third quarter 2026 results on October 13. Shares are trading higher in after-market hours, reflecting a modest gain.

2026. szept. 15. 23:06 UTC

News

Intuit Inc reported full-year revenue of $21.4 billion, a 14% increase. Shares are higher in after-market trading following the results and positive sentiment.

2026. szept. 15. 23:02 UTC

News

Walmart shares rose in after-market trading following a 5.1% growth in global enterprise, surpassing its average target and reflecting strong consumer spending.

2026. szept. 15. 23:02 UTC

News

Permian Resources shares are higher in after-market trading, with a current price of $24.49, reflecting strong long-term performance and a market cap of $20.51 billion.

2026. szept. 15. 23:02 UTC

News
Social Media

RTX shares are higher in after-market trading following the appointment of Jill Albertelli as president of Pratt & Whitney, effective January 1, 2027.

2026. szept. 15. 23:02 UTC

Correlated Moves
News

Chevron Corp shares are lower in after-market hours, influenced by a drop in the New York Empire State Manufacturing Index and ongoing supply risks.

2026. szept. 15. 23:02 UTC

News
Event

Trip.com Group Ltd reported second-quarter EPS of $1.07, exceeding expectations, while shares rose in after-market trading following the earnings announcement.

2026. szept. 15. 23:02 UTC

News

Target Corp shares are trading higher in after-market hours following the announcement of a new employee apparel line designed by Isaac Mizrahi.

2026. szept. 15. 23:02 UTC

Social Media
News

Celsius Holdings Inc. shares rose in after-hours trading following significant insider purchases totaling around $1 million by Director Damon DeSantis.

2026. szept. 15. 23:02 UTC

Correlated Moves
News

Qualcomm's after-market trading remains stable, reflecting Nasdaq 100 trends. The company reported $9.9 billion in revenue for the fiscal third quarter.

2026. szept. 15. 23:02 UTC

News

CrowdStrike Holdings shares are lower in after-market hours amid negative sentiment following a sharp decline in the New York Empire State Manufacturing Index.

2026. szept. 15. 23:02 UTC

News

Radiant Logistics shares are higher in after-market trading despite Glencore's $2 billion lawsuit alleging fraud and terminating business relationships with Radiant World.

2026. szept. 15. 23:02 UTC

Correlated Moves
News

Coinbase Global shares are lower in after-hours trading, influenced by declines in Bitcoin and Bitmine Immersion Technologies, amid a weak overall trading environment.

2026. szept. 15. 23:01 UTC

News

Boeing's recent Pentagon agreements include a $13.4 billion expansion of the KC-46 contract, though shares traded roughly flat in after-market hours.

2026. szept. 15. 23:01 UTC

News
Event

Evolution Petroleum shares are higher after reporting fourth-quarter revenue of $24.21 million, exceeding expectations, though adjusted EPS missed consensus estimates.

2026. szept. 15. 23:01 UTC

News

Interactive Brokers Group has integrated with X Cashtags, enabling US users to trade directly from tagged stock and crypto symbols. Shares are higher in after-market hours.

2026. szept. 15. 23:01 UTC

News

D.R. Horton announced a $5 billion stock repurchase program and raised its fiscal 2026 buyback target to $3.25 billion, contributing to after-market gains.

2026. szept. 15. 23:01 UTC

News

Alignment Healthcare Inc. shares are lower in after-market hours as bipartisan lawmakers introduce the Protecting Approved Care Act, impacting Medicare Advantage plans.

2026. szept. 15. 23:01 UTC

News

Coca-Cola Co plans a $10 billion investment in U.S. infrastructure by 2030. Shares showed little change during after-market hours, reflecting stable trading conditions.

Társak összehasonlítása

Árváltozás

Heron Therapeutics Inc Előrejelzés

Értékelési konszenzus

By TipRanks

Semleges

2 ratings

0

Vétel

2

Tartás

0

Eladás

Hangulat

By Acuity

129 / 339 Rangsor szerint Egészségügy

Hangulat hírek alapján

Neutral

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag feletti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.
help-icon Live chat